Editor's Choice by Seggie, Janet
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Bottom-lining the ‘zero-sum’ game
The Competition Commission’s previous interventions in the private 
healthcare market may have had unintended consequences (arguably 
skewing  the balance of power between dominant hospitals and medical 
aids, for example). However, the latest probe into unsustainable 
distortions in this sector deserves the support of all players – not least 
in their own self-interest. In Izindaba, Chris Bateman[1] looks at the 
legal amendment that gives serious ‘teeth’ to the impending probe 
(expected to take 2 years from 2014) – making it a much less benign 
creation than the one that forced the banking sector to lower client 
charges in 2006. Reportedly, corporate health executives are taking 
seriously legal advice to check out their systems for collusive price 
hiking and/or cut-throat anti-competitive behaviour that leaves the 
patient out of pocket and headed for an already overloaded public 
sector. It’s little wonder they’re paying attention given how hostile such 
purely commercial behaviour will render legislators, who are hugely 
invested in accelerating National Health Insurance so that healthcare 
becomes more generally affordable and accessible. What’s been a 
complex ‘zero-sum’ game with universal finger-pointing by key players 
could become a lot more transparent for the most important person 
of all – the patient.
Don’t blame the products for 
poisoning – blame the end-users!
An editorial[2] and two articles from the Tygerberg Poison Information 
Centre (TPIC) at Tygerberg Hospital,[3,4] on which hospitals and 
practitioners depend for advice on poisoning, reveal the scope of 
the problem. The good news is that the majority of cases reflect 
accidental exposure. We may think that pesticides are responsible for 
most human incidents, but the TIPC studies show that agricultural 
use of pesticides is responsible for fewer than 1% of exposures. 
The bad news is that end-users of poisonous substances are highly 
irresponsible in their storage and use! Safe storage, as directed 
on their labels, does not exist in most households, with risk of 
exposure for children and domestic animals. The illegal sale of 
decanted pesticides in unmarked containers by street vendors further 
compounds the problem. 
Healthcare professionals have insufficient knowledge about 
pesticides to be able to arrive at the correct diagnosis of toxicity and 
are frequently unable to accurately classify the agent(s) responsible 
for the patient’s illness. This is where expert advice from a PIC 
can facilitate correct treatment. A major ‘culprit’ is the carbamate 
pesticide aldicarb, sold as ‘rat poison’ (variously named ‘rat poison’, 
‘rattex’, ‘two step’, ‘galephirime’ or ‘halethrini’). Aldicarb is sold legally 
in SA for restricted agricultural use only, as Temik, but is sold illegally 
in unlabelled sachets. It is a cholinesterase inhibitor and not a long-
acting anticoagulant. 
In the TPIC’s experience the most common exposures involve 
paracetamol and household pesticides such as anticoagulant 
rodenticides, pyrethroids, some cholinesterase inhibitors and irritant/
corrosive cleaning agents, all of which are readily accessible on 
supermarket shelves. Begging the question: should these not be sold, 
as cigarettes and alcohol are, in restricted areas of the supermarkets to 
make the general public aware of their potential toxicity?
Vaccination against HPV for girls … 
and boys?
At any given time, 20% of women harbour cervical human 
papillomavirus (HPV), and two-thirds of invasive cervical cancers 
are attributable to oncogenic types 16 or 18. It gets worse: individuals 
infected with HIV are at an increased risk for HPV-related cancers.
The World Health Organization recommends that routine HPV 
vaccination be included in national immunisation programmes. Two 
vaccines, Cervarix (GlaxoSmithKline) (against HPV types 16 and 18), 
and Gardasil (Merck & Co.) (against HPV types 6, 11, 16 and 18) 
represent a major breakthrough for the prevention of cervical cancer. 
Although licensed for use in both the public and private healthcare 
sectors in SA, they are currently only available in the latter sector.
A vaccination demonstration project in KZN[5] has shown a high 
uptake, using school health teams to undertake the HPV vaccination 
of girls in schools. Its recommendations are relevant to a future 
national rollout of school-based HPV vaccination, as part of the 
integrated Department of Health primary healthcare and school 
health programmes.
Screening for HPV
High-risk human papillomavirus (hrHPV)-based screening tests offer 
the prospect of improving cervical cancer screening programmes. 
Women attending public sector primary healthcare clinics were 
invited to participate in Richter et al.’s[6] cervical cancer screening 
study. The results were unsettling. The prevalences of HPV infection 
and abnormal cytology were much higher than previously reported, 
reflecting sexual behavioural patterns, the largely unscreened and 
therefore untreated status of the female population, and the high 
background HIV prevalence.
Hepatitis B guideline 2013
Many South Africans have chronic hepatitis B virus (HBV) infection, 
leading to illness ranging from a low viraemic immune control 
state to progressive chronic hepatitis, and the potential to develop 
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cirrhosis, liver failure and hepatocellular carcinoma. There have 
been significant therapeutic advances over the past decade, and 
the decision to treat and the choice of therapy depend on both the 
phase of chronic infection and on patient factors. These therapeutic 
complexities are addressed in our 2013 guideline.[7]
Autism in Izindaba[8]
The SAMJ hopes that in this especially vulnerable country rife with 
HIV/AIDS, TB and malnutrition, doctors and the public won’t shy 
away from vaccinating our children. The link between autism and 
the measles, mumps, and rubella (MMR) vaccination has been 
thoroughly discredited:[9] the research was fraudulent. Following a 
General Medical Council (GMC) investigation and findings that 
‘the three authors acted unethically and dishonestly in preparing the 
research into the MMR vaccine’, the editors of the Lancet announced 
on 2 February 2010 that they ‘fully retract this paper from the 
published record.’[10] The case stands as one of the worst cases of 
fraudulent research in history! Our children (provided they aren’t 
immune-compromised) deserve to receive whatever vaccines are 
available!
TB diagnosis in children 
SA has one of the highest TB burdens in the world, after India and 
China, and one of the health targets set in the 2010 Millennium 
Development Goals is to halt and reverse the incidence of TB by 
2015. Diagnosing (disseminated) TB in children is difficult: often 
sputum can’t be obtained, necessitating gastric aspirates. Even then, 
identification of acid-fast bacilli is possible in less than 15% of 
samples and only 30 - 40% prove positive on culture. A positive 
tuberculin skin test, while reactive in most children within 3 - 6 
weeks after initial infection, may be delayed for up to 3 months. False-
negative TSTs occur in up to 10% of children who are TB culture-
positive, particularly in the context of severe TB illness, malnutrition, 
immunosuppression and the presence of other severe infections.
A paper from Red Cross Hospital[11] suggests a low threshold for 
undertaking bone marrow aspirate and trephine biopsy, especially in 
HIV-positive children in whom cytopenias, organomegaly and fever 
arouse suspicion of disseminated TB. 
Validation of the revised South African 
Triage Scale (SATS) for children
A survey of 2 000 children, presenting to 6 emergency units, has 
confirmed that the revised paediatric SATS is a robust and safe triage 
tool for children.[12] With a 91% sensitivity and a 95% negative predictive 
value, it has excellent ability to identify potentially seriously ill children. 
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